Corrigendum: γ′ Fibrinogen as a Predictor of Survival in Amyotrophic Lateral Sclerosis (Frontiers in Cardiovascular Medicine, (2021), 8, (715842), 10.3389/fcvm.2021.715842)

Ana Catarina Pronto-Laborinho, Catarina S. Lopes, Vasco A. Conceição, Marta Gromicho, Nuno C. Santos, Mamede de Carvalho, Filomena A. Carvalho

Research output: Contribution to journalComment/debate

Abstract

The Funding statement had an error in the reference of one project. Instead of PTDC/EMD-TLM/4644/2021, it should be PTDC/EMD-TLM/7289/2020. This work was supported by UID/BIM/50005/2019 and PTDC/EMD-TLM/7289/2020, a project funded by Fundação para a Ciência e a Tecnologia - Ministério da Ciência, Tecnologia e Ensino Superior (FCT-MCTES), through Fundos do Orçamento de Estado (Portugal). CSL also acknowledges FCT-MCTES fellowship PD/BD/135045/2017. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Original languageEnglish
Article number800151
JournalFrontiers in Cardiovascular Medicine
Volume8
DOIs
Publication statusPublished - 2021
Externally publishedYes

Keywords

  • amyotrophic lateral sclerosis
  • gamma′ fibrinogen
  • prognosis
  • respiratory function
  • survival

Fingerprint

Dive into the research topics of 'Corrigendum: γ′ Fibrinogen as a Predictor of Survival in Amyotrophic Lateral Sclerosis (Frontiers in Cardiovascular Medicine, (2021), 8, (715842), 10.3389/fcvm.2021.715842)'. Together they form a unique fingerprint.

Cite this